Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
Journal of Leukocyte Biology|December 21, 2005
Fine-tuning of immune responses by SLAM-related receptorsRauf Bhat, Philipp Eissmann, Johanna Endt, et al.International Journal of Cancer|February 13, 2007
Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cellsMostafa Jarahian, Carsten Watzl, Yasmin Issa, et al.European Journal of Immunology|April 1, 2015
Inhibition of NKp30- and 2B4-mediated NK cell activation by evolutionary different human and bovine CEACAM1 receptorsWolfgang Merkt, Doris Urlaub, Stephan Meinke, et al.Cells|November 11, 2022
Inhibition of Glucose Uptake Blocks Proliferation but Not Cytotoxic Activity of NK CellsLea Katharina Picard, Elisabeth Littwitz-Salomon, Herbert Waldmann, et al.Trials|January 31, 2020
Protocol for the Optimune trial: a randomized controlled trial evaluating a novel Internet intervention for breast cancer survivorsFranziska Holtdirk, Anja Mehnert, Mario Weiss, et al.Journal of Medicinal Chemistry|October 4, 2023
Synthesis and Binding Mode Predictions of Novel Siglec-7 LigandsMartin Frank, Elena Kuhfeldt, Jonathan Cramer, et al.Immunity, Inflammation and Disease|September 9, 2021
SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staffDoris Urlaub, Natalie Wolfsdorff, Deniz Durak, et al.Neurobiology of Stress|February 2, 2021
To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2Eva M J Peters, Manfred Schedlowski, Carsten Watzl, et al.Science Signaling|June 3, 2011
Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cellsSven Mesecke, Doris Urlaub, Hauke Busch, et al.Molecular Immunology|August 19, 2007
Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAPStefan Mehrle, Jan Schmidt, Markus W Büchler, et al.Pageof 15